Relation of HTLV-III seropositivity and lymphadenopathy. NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Relation of HTLV-III seropositivity and lymphadenopathy.

Can Med Assoc J. 1985 Jul 15;133(2):111-2. Unique Identifier : AIDSLINE MED/85227795
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR

Abstract: Testing for antibody to human T-lymphotropic retrovirus (HTLV-III) was carried out in five groups of homosexual men: 250 without lymphadenopathy (control group), 37 with slight or nonpersistent lymph node enlargement (intermediate group), 141 with persistent generalized lymphadenopathy, 32 with persistent generalized lymphadenopathy who underwent biopsy and 11 in whom acquired immune deficiency syndrome (AIDS) was diagnosed. The rates of HTLV-III seropositivity in the five groups were 18%, 32%, 61%, 94% and 91% respectively.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY Antibodies, Viral/*ANALYSIS British Columbia Enzyme-Linked Immunosorbent Assay Homosexuality Human HTLV-BLV Viruses/*IMMUNOLOGY Lymphatic Diseases/*IMMUNOLOGY Male Prospective Studies Support, Non-U.S. Gov't JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/immunologyantibodies,viral/KWDanalysisbritishcolumbiaenzyme-linkedimmunosorbentassayhomosexualityhumanhtlv-blvviruses/KWDimmunologylymphaticdiseases/KWDimmunologymaleprospectivestudiessupport,non-uKWDsKWDgov'tjournalarticle
851030
M85A0083

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .